ATE416012T1 - Für die externe anwendung auf der haut vorgesehenes mittel mit einem salz eines ascorbinsäurederivats, verfahren zur stabilisierung des mittels für die externe anwendung auf der haut - Google Patents

Für die externe anwendung auf der haut vorgesehenes mittel mit einem salz eines ascorbinsäurederivats, verfahren zur stabilisierung des mittels für die externe anwendung auf der haut

Info

Publication number
ATE416012T1
ATE416012T1 AT04792623T AT04792623T ATE416012T1 AT E416012 T1 ATE416012 T1 AT E416012T1 AT 04792623 T AT04792623 T AT 04792623T AT 04792623 T AT04792623 T AT 04792623T AT E416012 T1 ATE416012 T1 AT E416012T1
Authority
AT
Austria
Prior art keywords
external use
agent
skin
salt
ascorbic acid
Prior art date
Application number
AT04792623T
Other languages
English (en)
Inventor
Eiko Kato
Tadashi Yoneda
Eiji Ogata
Original Assignee
Showa Denko Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Denko Kk filed Critical Showa Denko Kk
Application granted granted Critical
Publication of ATE416012T1 publication Critical patent/ATE416012T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
AT04792623T 2003-10-14 2004-10-13 Für die externe anwendung auf der haut vorgesehenes mittel mit einem salz eines ascorbinsäurederivats, verfahren zur stabilisierung des mittels für die externe anwendung auf der haut ATE416012T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003353669 2003-10-14
US51285703P 2003-10-22 2003-10-22
JP2004130206 2004-04-26
US56752704P 2004-05-04 2004-05-04
PCT/JP2004/015457 WO2005034903A1 (en) 2003-10-14 2004-10-13 Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer

Publications (1)

Publication Number Publication Date
ATE416012T1 true ATE416012T1 (de) 2008-12-15

Family

ID=46045498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04792623T ATE416012T1 (de) 2003-10-14 2004-10-13 Für die externe anwendung auf der haut vorgesehenes mittel mit einem salz eines ascorbinsäurederivats, verfahren zur stabilisierung des mittels für die externe anwendung auf der haut

Country Status (6)

Country Link
US (1) US8278350B2 (de)
EP (1) EP1689494B1 (de)
AT (1) ATE416012T1 (de)
ES (1) ES2317067T3 (de)
TW (1) TW200520753A (de)
WO (1) WO2005034903A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
KR100691540B1 (ko) * 2006-06-22 2007-03-12 주식회사 펩트론 펩타이드가 결합된 안정화된 비타민 ｃ 유도체, 이의제조방법 및 이를 함유하는 조성물
US7985722B2 (en) * 2006-07-27 2011-07-26 Aurora Advanced Beauty Labs Rhamnolipid-based formulations
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
EP2455134B1 (de) 2007-04-19 2016-05-11 Mary Kay, Inc. Magnolienextrakthaltige Zusammensetzungen
FR2916977A1 (fr) * 2007-06-06 2008-12-12 Engelhard Lyon Sa STIMULATION DE LA SYNTHESE DES RECPTEURS MCR1, MCR2 ET µ OPIOIDE.
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US8309143B2 (en) 2010-04-16 2012-11-13 Doreen Campbell Hair and scalp care formulations for treating and preventing acne and related skin conditions
JP5690208B2 (ja) * 2011-05-12 2015-03-25 昭和電工株式会社 皮膚外用剤およびその製造方法
JP5856761B2 (ja) * 2011-06-09 2016-02-10 昭和電工株式会社 皮膚外用剤およびその製造方法
US20170135921A1 (en) 2015-11-17 2017-05-18 Funai Electric Co., Ltd Color ink set for cosmetic application
EP3380201B8 (de) * 2015-11-26 2020-10-28 MP2 Cosmetic Solutions Komplex gegen verschmutzung mit öligen und wässrigen calendula-extrakten und einem wässrigen extrakt aus lilium-candidum-zwiebeln und verwendungen davon
US20170319466A1 (en) * 2016-01-21 2017-11-09 Penta 5 USA, LLC Topical mosquito control product with sunscreen
WO2017127821A1 (en) * 2016-01-21 2017-07-27 Penta 5 USA, LLC Topical mosquito control product with sunscreen
US11045414B2 (en) * 2016-01-21 2021-06-29 Penta 5 USA, LLC Topical mosquito control product
US20190380350A1 (en) * 2016-01-21 2019-12-19 Penta 5 USA, LLC Topical mosquito control product with sunscreen
US11219222B2 (en) 2016-01-21 2022-01-11 Penta 5 USA, LLC Topical mosquito control product
WO2017127799A1 (en) * 2016-01-21 2017-07-27 Penta 5 USA, LLC Topical mosquito control product
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN107811279A (zh) * 2017-09-25 2018-03-20 云南中医学院 一种药食用真菌发酵核桃青皮的方法及其发酵制品与应用
CN112237901A (zh) * 2020-10-16 2021-01-19 青岛蓝色地球大数据科技有限公司 一种用于处理含铬废水的新型复合改性蒙脱石的制备方法
FR3124390B1 (fr) * 2021-06-28 2025-05-23 Oreal Composition cosmétique transparente avec acide ascorbique, polymère cationique et glycol

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08113525A (ja) 1994-10-14 1996-05-07 Risuburan:Kk 美白用皮膚外用剤
DE19745506A1 (de) * 1997-10-15 1999-04-22 Basf Ag Verwendung von Ascorbyl-2-phosphorsäureestern zur Stabilisierung von Vitamin A und/oder Vitamin A-Derivaten in kosmetischen und pharmazeutischen Zubereitung
CN1300215A (zh) * 1998-05-15 2001-06-20 昭和电工株式会社 皮肤病防治剂
JP4099267B2 (ja) * 1998-08-07 2008-06-11 株式会社紀文フードケミファ 乳化剤および乳化組成物
JP2002003330A (ja) 2000-06-21 2002-01-09 Toyo Beauty Kk 化粧料
JP4637441B2 (ja) 2001-03-23 2011-02-23 ロート製薬株式会社 アスコルビン酸を含有する外皮用組成物
JP2003176217A (ja) 2001-12-12 2003-06-24 Showa Denko Kk 皮膚外用剤
DE10206759A1 (de) * 2002-02-19 2003-08-28 Dragoco Gerberding Co Ag Synergistische Mischungen von 1,2-Alkandiolen
JP2003267856A (ja) 2002-03-18 2003-09-25 Showa Denko Kk しわ防止用化粧料
JP4111856B2 (ja) * 2002-04-12 2008-07-02 昭和電工株式会社 安定化されたアスコルビン酸誘導体

Also Published As

Publication number Publication date
US20070140998A1 (en) 2007-06-21
WO2005034903A1 (en) 2005-04-21
ES2317067T3 (es) 2009-04-16
EP1689494B1 (de) 2008-12-03
US8278350B2 (en) 2012-10-02
EP1689494A1 (de) 2006-08-16
TW200520753A (en) 2005-07-01

Similar Documents

Publication Publication Date Title
ATE416012T1 (de) Für die externe anwendung auf der haut vorgesehenes mittel mit einem salz eines ascorbinsäurederivats, verfahren zur stabilisierung des mittels für die externe anwendung auf der haut
DE602004030568D1 (de) ZUSAMMENSETZUNG ZUR ÄUßERLICHEN ANWENDUNG
DE602008005735D1 (de) Verfahren und vorrichtung für eeg-elektrode mit schnellem andruck
DE60333873D1 (de) Zubereitungen die Lotusextrakte und Methyldonatoren enthalten
WO2012018888A3 (en) An antiseptic liquid formulation, a method for its use, and a method for preparing the formulation
ATE394365T1 (de) Verfahren zur synthese von verbindungen vom ceramidtyp
MY140581A (en) Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
DE50209378D1 (de) Markierungslösung zur fälschungssicheren kennzeichnung eines wertgegenstands, aus der markierungslösung hergestellte markierung sowie verfahren zur markierung eines wertgegenstands
DE60311135D1 (de) Vorrichtung und verfahren zur behandlung eines flüssigen mediums mittels ultraschall zur verhinderung des wachstums von hyperproliferativen oder infizierten zellen
ATE354295T1 (de) Verfahren zur verringerung der bitterkeit von aminosäure
ATE468106T1 (de) Gel zur behandlung von wunden
ATE268587T1 (de) Gebrauch von silicongummi zur stabilisierung von ascorbinsaüre und vorbereitungen die diese zusammensetzungen enthalten
FR3004939B1 (fr) Huile essentielle de satureja montana a forte teneur en geraniol, et utilisation pour traiter les peaux grasses et/ou les defauts esthetiques associes
EP2163238A3 (de) Zusammensetzung zur Hautaufhellung enthaltend Sulforaphan oder Sulforaphen oder deren Derivate
ATE550011T1 (de) Verfahren zur depilation und depilierausrüstung
ATE537808T1 (de) Verfahren zur depilation und depilierausrüstung
ATE493980T1 (de) Verwendung eines diamidderivats zur verhinderung der chronischen transplantatabstossung
DE602004031303D1 (de) Verfahren und zusammensetzungen für die behandlung von hautwunden
DE60227065D1 (de) Zusammensetzung und verfahren zur behandlung von magnesiumlegierungen
DE50005609D1 (de) Verfahren zur herstellung von optisch reinen tetrahydropterinen und derivaten, im speziellen optisch reiner tetrahydrofolsäure und ihren derivaten, durch stereospezifische hydrierung
ATE337796T1 (de) Verfahren zur herstellung von hyperpolarisiertem 129xe
ATE451950T1 (de) Verfahren zur verminderung der talgproduktion und porengrösse
ATE548082T1 (de) Mittel zur behandlung der haare und der kopfhaut
EP2364689A3 (de) Mentholhaltige Zahnputz-Zusammensetzung mit reduzierter Bitterwahrnehmung
WO2006069072A3 (en) Method and composition for reducing the appearance of wrinkles

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties